- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Semi-solid Dosage market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Semi-solid Dosage size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Semi-solid Dosage market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Semi-solid Dosage market is split by Type and by Application. For the period 2016-2027, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ointment
Paste
Plaster
Gel
Market segment by Application can be divided into
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Other
The key market players for global Semi-solid Dosage market are listed below:
Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera
Crown Laboratories
Akorn
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics
Mylan N.V.
Encore Dermatology
LEO Pharma
Almirall, S.A
Aclaris Therapeutics
Taro Pharmaceutical Industries
Teligent Pharma
Perrigo Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Semi-solid Dosage product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Semi-solid Dosage, with price, sales, revenue and global market share of Semi-solid Dosage from 2019 to 2021.
Chapter 3, the Semi-solid Dosage competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Semi-solid Dosage breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2027.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2027.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Semi-solid Dosage market forecast, by regions, type and application, with sales and revenue, from 2021 to 2027.
Chapter 12, 13 and 14, to describe Semi-solid Dosage sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Semi-solid Dosage Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Semi-solid Dosage Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ointment
1.2.3 Paste
1.2.4 Plaster
1.2.5 Gel
1.3 Market Analysis by Application
1.3.1 Overview: Global Semi-solid Dosage Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Skin
1.3.3 Nasal Cavity
1.3.4 Vaginal Cavity
1.3.5 Rectal Cavity
1.3.6 Other
1.4 Global Semi-solid Dosage Market Size & Forecast
1.4.1 Global Semi-solid Dosage Sales in Value (2016-2026))
1.4.2 Global Semi-solid Dosage Sales in Volume (2016-2026)
1.4.3 Global Semi-solid Dosage Price by Type (2016-2026) & (US$/Dose)
1.5 Global Semi-solid Dosage Production Capacity Analysis
1.5.1 Global Semi-solid Dosage Total Production Capacity (2016-2026)
1.5.2 Global Semi-solid Dosage Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Semi-solid Dosage Market Drivers
1.6.2 Semi-solid Dosage Market Restraints
1.6.3 Semi-solid Dosage Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Semi-solid Dosage Product and Services
2.1.4 Johnson & Johnson Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Merck & Co
2.2.1 Merck & Co Details
2.2.2 Merck & Co Major Business
2.2.3 Merck & Co Semi-solid Dosage Product and Services
2.2.4 Merck & Co Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Semi-solid Dosage Product and Services
2.3.4 Bayer AG Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Hisamitsu Pharmaceutical
2.4.1 Hisamitsu Pharmaceutical Details
2.4.2 Hisamitsu Pharmaceutical Major Business
2.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Product and Services
2.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Product and Services
2.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Cipla Ltd
2.6.1 Cipla Ltd Details
2.6.2 Cipla Ltd Major Business
2.6.3 Cipla Ltd Semi-solid Dosage Product and Services
2.6.4 Cipla Ltd Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nestle SA
2.7.1 Nestle SA Details
2.7.2 Nestle SA Major Business
2.7.3 Nestle SA Semi-solid Dosage Product and Services
2.7.4 Nestle SA Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Semi-solid Dosage Product and Services
2.8.4 Novartis AG Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 GlaxoSmithKline plc
2.9.1 GlaxoSmithKline plc Details
2.9.2 GlaxoSmithKline plc Major Business
2.9.3 GlaxoSmithKline plc Semi-solid Dosage Product and Services
2.9.4 GlaxoSmithKline plc Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Bausch Health Companies
2.10.1 Bausch Health Companies Details
2.10.2 Bausch Health Companies Major Business
2.10.3 Bausch Health Companies Semi-solid Dosage Product and Services
2.10.4 Bausch Health Companies Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Semi-solid Dosage Product and Services
2.11.4 Allergan Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Biofrontera
2.12.1 Biofrontera Details
2.12.2 Biofrontera Major Business
2.12.3 Biofrontera Semi-solid Dosage Product and Services
2.12.4 Biofrontera Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Crown Laboratories
2.13.1 Crown Laboratories Details
2.13.2 Crown Laboratories Major Business
2.13.3 Crown Laboratories Semi-solid Dosage Product and Services
2.13.4 Crown Laboratories Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Akorn
2.14.1 Akorn Details
2.14.2 Akorn Major Business
2.14.3 Akorn Semi-solid Dosage Product and Services
2.14.4 Akorn Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Ingenus Pharmaceuticals
2.15.1 Ingenus Pharmaceuticals Details
2.15.2 Ingenus Pharmaceuticals Major Business
2.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Product and Services
2.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Sun Pharmaceuticals
2.16.1 Sun Pharmaceuticals Details
2.16.2 Sun Pharmaceuticals Major Business
2.16.3 Sun Pharmaceuticals Semi-solid Dosage Product and Services
2.16.4 Sun Pharmaceuticals Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Crescita Therapeutics
2.17.1 Crescita Therapeutics Details
2.17.2 Crescita Therapeutics Major Business
2.17.3 Crescita Therapeutics Semi-solid Dosage Product and Services
2.17.4 Crescita Therapeutics Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Mylan N.V.
2.18.1 Mylan N.V. Details
2.18.2 Mylan N.V. Major Business
2.18.3 Mylan N.V. Semi-solid Dosage Product and Services
2.18.4 Mylan N.V. Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Encore Dermatology
2.19.1 Encore Dermatology Details
2.19.2 Encore Dermatology Major Business
2.19.3 Encore Dermatology Semi-solid Dosage Product and Services
2.19.4 Encore Dermatology Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 LEO Pharma
2.20.1 LEO Pharma Details
2.20.2 LEO Pharma Major Business
2.20.3 LEO Pharma Semi-solid Dosage Product and Services
2.20.4 LEO Pharma Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Almirall, S.A
2.21.1 Almirall, S.A Details
2.21.2 Almirall, S.A Major Business
2.21.3 Almirall, S.A Semi-solid Dosage Product and Services
2.21.4 Almirall, S.A Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Aclaris Therapeutics
2.22.1 Aclaris Therapeutics Details
2.22.2 Aclaris Therapeutics Major Business
2.22.3 Aclaris Therapeutics Semi-solid Dosage Product and Services
2.22.4 Aclaris Therapeutics Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Taro Pharmaceutical Industries
2.23.1 Taro Pharmaceutical Industries Details
2.23.2 Taro Pharmaceutical Industries Major Business
2.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Product and Services
2.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Teligent Pharma
2.24.1 Teligent Pharma Details
2.24.2 Teligent Pharma Major Business
2.24.3 Teligent Pharma Semi-solid Dosage Product and Services
2.24.4 Teligent Pharma Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Perrigo Pharma
2.25.1 Perrigo Pharma Details
2.25.2 Perrigo Pharma Major Business
2.25.3 Perrigo Pharma Semi-solid Dosage Product and Services
2.25.4 Perrigo Pharma Semi-solid Dosage Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Semi-solid Dosage Sales by Manufacturer
3.1 Global Semi-solid Dosage Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Semi-solid Dosage Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Semi-solid Dosage
3.4 Market Concentration Rate
3.4.1 Top 3 Semi-solid Dosage Manufacturer Market Share
3.4.2 Top 6 Semi-solid Dosage Manufacturer Market Share
3.5 Global Semi-solid Dosage Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Semi-solid Dosage Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Semi-solid Dosage Market Size by Region
4.1.1 Global Semi-solid Dosage Sales in Volume by Region (2016-2026)
4.1.2 Global Semi-solid Dosage Revenue by Region (2016-2026)
4.2 North America Semi-solid Dosage Revenue (2016-2026)
4.3 Europe Semi-solid Dosage Revenue (2016-2026)
4.4 Asia-Pacific Semi-solid Dosage Revenue (2016-2026)
4.5 South America Semi-solid Dosage Revenue (2016-2026)
4.6 Middle East and Africa Semi-solid Dosage Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Semi-solid Dosage Sales in Volume by Type (2016-2026)
5.2 Global Semi-solid Dosage Revenue by Type (2016-2026)
5.3 Global Semi-solid Dosage Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Semi-solid Dosage Sales in Volume by Application (2016-2026)
6.2 Global Semi-solid Dosage Revenue by Application (2016-2026)
6.3 Global Semi-solid Dosage Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Semi-solid Dosage Sales by Type (2016-2026)
7.2 North America Semi-solid Dosage Sales by Application (2016-2026)
7.3 North America Semi-solid Dosage Market Size by Country
7.3.1 North America Semi-solid Dosage Sales in Volume by Country (2016-2026)
7.3.2 North America Semi-solid Dosage Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Semi-solid Dosage Sales by Type (2016-2026)
8.2 Europe Semi-solid Dosage Sales by Application (2016-2026)
8.3 Europe Semi-solid Dosage Market Size by Country
8.3.1 Europe Semi-solid Dosage Sales in Volume by Country (2016-2026)
8.3.2 Europe Semi-solid Dosage Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Semi-solid Dosage Sales by Type (2016-2026)
9.2 Asia-Pacific Semi-solid Dosage Sales by Application (2016-2026)
9.3 Asia-Pacific Semi-solid Dosage Market Size by Region
9.3.1 Asia-Pacific Semi-solid Dosage Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Semi-solid Dosage Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Semi-solid Dosage Sales by Type (2016-2026)
10.2 South America Semi-solid Dosage Sales by Application (2016-2026)
10.3 South America Semi-solid Dosage Market Size by Country
10.3.1 South America Semi-solid Dosage Sales in Volume by Country (2016-2026)
10.3.2 South America Semi-solid Dosage Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Semi-solid Dosage Sales by Type (2016-2026)
11.2 Middle East & Africa Semi-solid Dosage Sales by Application (2016-2026)
11.3 Middle East & Africa Semi-solid Dosage Market Size by Country
11.3.1 Middle East & Africa Semi-solid Dosage Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Semi-solid Dosage Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Semi-solid Dosage Typical Distributors
12.3 Semi-solid Dosage Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Semi-solid Dosage Revenue by Type, (USD Million), 2021-2026
Table 2. Global Semi-solid Dosage Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Semi-solid Dosage Product and Services
Table 6. Johnson & Johnson Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 8. Merck & Co Major Business
Table 9. Merck & Co Semi-solid Dosage Product and Services
Table 10. Merck & Co Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 12. Bayer AG Major Business
Table 13. Bayer AG Semi-solid Dosage Product and Services
Table 14. Bayer AG Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Hisamitsu Pharmaceutical Major Business
Table 17. Hisamitsu Pharmaceutical Semi-solid Dosage Product and Services
Table 18. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Glenmark Pharmaceuticals Major Business
Table 21. Glenmark Pharmaceuticals Semi-solid Dosage Product and Services
Table 22. Glenmark Pharmaceuticals Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Ltd Major Business
Table 25. Cipla Ltd Semi-solid Dosage Product and Services
Table 26. Cipla Ltd Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nestle SA Basic Information, Manufacturing Base and Competitors
Table 28. Nestle SA Major Business
Table 29. Nestle SA Semi-solid Dosage Product and Services
Table 30. Nestle SA Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Semi-solid Dosage Product and Services
Table 34. Novartis AG Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline plc Major Business
Table 37. GlaxoSmithKline plc Semi-solid Dosage Product and Services
Table 38. GlaxoSmithKline plc Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table 40. Bausch Health Companies Major Business
Table 41. Bausch Health Companies Semi-solid Dosage Product and Services
Table 42. Bausch Health Companies Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Major Business
Table 45. Allergan Semi-solid Dosage Product and Services
Table 46. Allergan Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Biofrontera Basic Information, Manufacturing Base and Competitors
Table 48. Biofrontera Major Business
Table 49. Biofrontera Semi-solid Dosage Product and Services
Table 50. Biofrontera Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Crown Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. Crown Laboratories Major Business
Table 53. Crown Laboratories Semi-solid Dosage Product and Services
Table 54. Crown Laboratories Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Akorn Basic Information, Manufacturing Base and Competitors
Table 56. Akorn Major Business
Table 57. Akorn Semi-solid Dosage Product and Services
Table 58. Akorn Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Ingenus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Ingenus Pharmaceuticals Major Business
Table 61. Ingenus Pharmaceuticals Semi-solid Dosage Product and Services
Table 62. Ingenus Pharmaceuticals Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Sun Pharmaceuticals Major Business
Table 65. Sun Pharmaceuticals Semi-solid Dosage Product and Services
Table 66. Sun Pharmaceuticals Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Crescita Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Crescita Therapeutics Major Business
Table 69. Crescita Therapeutics Semi-solid Dosage Product and Services
Table 70. Crescita Therapeutics Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 72. Mylan N.V. Major Business
Table 73. Mylan N.V. Semi-solid Dosage Product and Services
Table 74. Mylan N.V. Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Encore Dermatology Basic Information, Manufacturing Base and Competitors
Table 76. Encore Dermatology Major Business
Table 77. Encore Dermatology Semi-solid Dosage Product and Services
Table 78. Encore Dermatology Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 80. LEO Pharma Major Business
Table 81. LEO Pharma Semi-solid Dosage Product and Services
Table 82. LEO Pharma Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Almirall, S.A Basic Information, Manufacturing Base and Competitors
Table 84. Almirall, S.A Major Business
Table 85. Almirall, S.A Semi-solid Dosage Product and Services
Table 86. Almirall, S.A Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Aclaris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 88. Aclaris Therapeutics Major Business
Table 89. Aclaris Therapeutics Semi-solid Dosage Product and Services
Table 90. Aclaris Therapeutics Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Taro Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 92. Taro Pharmaceutical Industries Major Business
Table 93. Taro Pharmaceutical Industries Semi-solid Dosage Product and Services
Table 94. Taro Pharmaceutical Industries Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Teligent Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Teligent Pharma Major Business
Table 97. Teligent Pharma Semi-solid Dosage Product and Services
Table 98. Teligent Pharma Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Perrigo Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Perrigo Pharma Major Business
Table 101. Perrigo Pharma Semi-solid Dosage Product and Services
Table 102. Perrigo Pharma Semi-solid Dosage Sales (Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Global Semi-solid Dosage Sales by Manufacturer (2019-2021e) & (Dose)
Table 104. Global Semi-solid Dosage Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 105. Market Position of Manufacturers in Semi-solid Dosage, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 106. Global Semi-solid Dosage Production Capacity by Company, (Dose): 2020 VS 2021
Table 107. Head Office and Semi-solid Dosage Production Site of Key Manufacturer
Table 108. Semi-solid Dosage New Entrant and Capacity Expansion Plans
Table 109. Semi-solid Dosage Mergers & Acquisitions in the Past Five Years
Table 110. Global Semi-solid Dosage Sales by Region (2016-2021e) & (Dose)
Table 111. Global Semi-solid Dosage Sales by Region (2021-2026) & (Dose)
Table 112. Global Semi-solid Dosage Revenue by Region (2016-2021e) & (USD Million)
Table 113. Global Semi-solid Dosage Revenue by Region (2021-2026) & (USD Million)
Table 114. Global Semi-solid Dosage Sales by Type (2016-2021e) & (Dose)
Table 115. Global Semi-solid Dosage Sales by Type (2021-2026) & (Dose)
Table 116. Global Semi-solid Dosage Revenue by Type (2016-2021e) & (USD Million)
Table 117. Global Semi-solid Dosage Revenue by Type (2021-2026) & (USD Million)
Table 118. Global Semi-solid Dosage Price by Type (2016-2021e) & (US$/Dose)
Table 119. Global Semi-solid Dosage Price by Type (2021-2026) & (US$/Dose)
Table 120. Global Semi-solid Dosage Sales by Application (2016-2021e) & (Dose)
Table 121. Global Semi-solid Dosage Sales by Application (2021-2026) & (Dose)
Table 122. Global Semi-solid Dosage Revenue by Application (2016-2021e) & (USD Million)
Table 123. Global Semi-solid Dosage Revenue by Application (2021-2026) & (USD Million)
Table 124. Global Semi-solid Dosage Price by Application (2016-2021e) & (US$/Dose)
Table 125. Global Semi-solid Dosage Price by Application (2021-2026) & (US$/Dose)
Table 126. North America Semi-solid Dosage Sales by Country (2016-2021e) & (Dose)
Table 127. North America Semi-solid Dosage Sales by Country (2021-2026) & (Dose)
Table 128. North America Semi-solid Dosage Revenue by Country (2016-2021e) & (USD Million)
Table 129. North America Semi-solid Dosage Revenue by Country (2021-2026) & (USD Million)
Table 130. North America Semi-solid Dosage Sales by Type (2016-2021e) & (Dose)
Table 131. North America Semi-solid Dosage Sales by Type (2021-2026) & (Dose)
Table 132. North America Semi-solid Dosage Sales by Application (2016-2021e) & (Dose)
Table 133. North America Semi-solid Dosage Sales by Application (2021-2026) & (Dose)
Table 134. Europe Semi-solid Dosage Sales by Country (2016-2021e) & (Dose)
Table 135. Europe Semi-solid Dosage Sales by Country (2021-2026) & (Dose)
Table 136. Europe Semi-solid Dosage Revenue by Country (2016-2021e) & (USD Million)
Table 137. Europe Semi-solid Dosage Revenue by Country (2021-2026) & (USD Million)
Table 138. Europe Semi-solid Dosage Sales by Type (2016-2021e) & (Dose)
Table 139. Europe Semi-solid Dosage Sales by Type (2021-2026) & (Dose)
Table 140. Europe Semi-solid Dosage Sales by Application (2016-2021e) & (Dose)
Table 141. Europe Semi-solid Dosage Sales by Application (2021-2026) & (Dose)
Table 142. Asia-Pacific Semi-solid Dosage Sales by Region (2016-2021e) & (Dose)
Table 143. Asia-Pacific Semi-solid Dosage Sales by Region (2021-2026) & (Dose)
Table 144. Asia-Pacific Semi-solid Dosage Revenue by Region (2016-2021e) & (USD Million)
Table 145. Asia-Pacific Semi-solid Dosage Revenue by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Semi-solid Dosage Sales by Type (2016-2021e) & (Dose)
Table 147. Asia-Pacific Semi-solid Dosage Sales by Type (2021-2026) & (Dose)
Table 148. Asia-Pacific Semi-solid Dosage Sales by Application (2016-2021e) & (Dose)
Table 149. Asia-Pacific Semi-solid Dosage Sales by Application (2021-2026) & (Dose)
Table 150. South America Semi-solid Dosage Sales by Country (2016-2021e) & (Dose)
Table 151. South America Semi-solid Dosage Sales by Country (2021-2026) & (Dose)
Table 152. South America Semi-solid Dosage Revenue by Country (2016-2021e) & (USD Million)
Table 153. South America Semi-solid Dosage Revenue by Country (2021-2026) & (USD Million)
Table 154. South America Semi-solid Dosage Sales by Type (2016-2021e) & (Dose)
Table 155. South America Semi-solid Dosage Sales by Type (2021-2026) & (Dose)
Table 156. South America Semi-solid Dosage Sales by Application (2016-2021e) & (Dose)
Table 157. South America Semi-solid Dosage Sales by Application (2021-2026) & (Dose)
Table 158. Middle East & Africa Semi-solid Dosage Sales by Country (2016-2021e) & (Dose)
Table 159. Middle East & Africa Semi-solid Dosage Sales by Country (2021-2026) & (Dose)
Table 160. Middle East & Africa Semi-solid Dosage Revenue by Country (2016-2021e) & (USD Million)
Table 161. Middle East & Africa Semi-solid Dosage Revenue by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Semi-solid Dosage Sales by Type (2016-2021e) & (Dose)
Table 163. Middle East & Africa Semi-solid Dosage Sales by Type (2021-2026) & (Dose)
Table 164. Middle East & Africa Semi-solid Dosage Sales by Application (2016-2021e) & (Dose)
Table 165. Middle East & Africa Semi-solid Dosage Sales by Application (2021-2026) & (Dose)
Table 166. Direct Channel Pros & Cons
Table 167. Indirect Channel Pros & Cons
Table 168. Semi-solid Dosage Typical Distributors
Table 169. Semi-solid Dosage Typical Customers
List of Figures
Figure 1. Semi-solid Dosage Picture
Figure 2. Global Semi-solid Dosage Sales Market Share by Type in 2020
Figure 3. Ointment
Figure 4. Paste
Figure 5. Plaster
Figure 6. Gel
Figure 7. Global Semi-solid Dosage Sales Market Share by Application in 2020
Figure 8. Skin
Figure 9. Nasal Cavity
Figure 10. Vaginal Cavity
Figure 11. Rectal Cavity
Figure 12. Other
Figure 13. Global Semi-solid Dosage Market Size, (USD Million) & (Dose): 2020 VS 2021 VS 2026
Figure 14. Global Semi-solid Dosage Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Semi-solid Dosage Sales (2016-2026) & (Dose)
Figure 16. Global Semi-solid Dosage Price by Type (2016-2026) & (US$/Dose)
Figure 17. Global Semi-solid Dosage Production Capacity (2016-2026) & (Dose)
Figure 18. Global Semi-solid Dosage Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Semi-solid Dosage Market Drivers
Figure 20. Semi-solid Dosage Market Restraints
Figure 21. Semi-solid Dosage Market Trends
Figure 22. Global Semi-solid Dosage Sales Market Share by Manufacturer in 2020
Figure 23. Global Semi-solid Dosage Revenue Market Share by Manufacturer in 2020
Figure 24. Semi-solid Dosage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Semi-solid Dosage Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Semi-solid Dosage Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Semi-solid Dosage Sales Market Share by Region (2016-2026)
Figure 28. Global Semi-solid Dosage Revenue Market Share by Region (2016-2026)
Figure 29. North America Semi-solid Dosage Revenue (2016-2026) & (USD Million)
Figure 30. Europe Semi-solid Dosage Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Semi-solid Dosage Revenue (2016-2026) & (USD Million)
Figure 32. South America Semi-solid Dosage Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Semi-solid Dosage Revenue (2016-2026) & (USD Million)
Figure 34. Global Semi-solid Dosage Sales Market Share by Type (2016-2026)
Figure 35. Global Semi-solid Dosage Revenue Market Share by Type (2016-2026)
Figure 36. Global Semi-solid Dosage Price by Type (2016-2026) & (US$/Dose)
Figure 37. Global Semi-solid Dosage Sales Market Share by Application (2016-2026)
Figure 38. Global Semi-solid Dosage Revenue Market Share by Application (2016-2026)
Figure 39. Global Semi-solid Dosage Price by Application (2016-2026) & (US$/Dose)
Figure 40. North America Semi-solid Dosage Sales Market Share by Type (2016-2026)
Figure 41. North America Semi-solid Dosage Sales Market Share by Application (2016-2026)
Figure 42. North America Semi-solid Dosage Sales Market Share by Country (2016-2026)
Figure 43. North America Semi-solid Dosage Revenue Market Share by Country (2016-2026)
Figure 44. United States Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Semi-solid Dosage Sales Market Share by Type (2016-2026)
Figure 48. Europe Semi-solid Dosage Sales Market Share by Application (2016-2026)
Figure 49. Europe Semi-solid Dosage Sales Market Share by Country (2016-2026)
Figure 50. Europe Semi-solid Dosage Revenue Market Share by Country (2016-2026)
Figure 51. Germany Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Semi-solid Dosage Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Semi-solid Dosage Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Semi-solid Dosage Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Semi-solid Dosage Revenue Market Share by Region (2016-2026)
Figure 60. China Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Semi-solid Dosage Sales Market Share by Type (2016-2026)
Figure 67. South America Semi-solid Dosage Sales Market Share by Application (2016-2026)
Figure 68. South America Semi-solid Dosage Sales Market Share by Country (2016-2026)
Figure 69. South America Semi-solid Dosage Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Semi-solid Dosage Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Semi-solid Dosage Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Semi-solid Dosage Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Semi-solid Dosage Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Semi-solid Dosage Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
